Inhibition of Protein N-Myristoylation: A Therapeutic Protocol in Developing Anticancer Agents

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|12|6|667-692

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.12, Iss.6, 2012-07, pp. : 667-692

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Protein Phosphatase Inhibition: Structure Based Design. Towards New Therapeutic Agents

By  

Current Pharmaceutical Design, Vol. 10, Iss. 10, 2004-04 ,pp. : 1139-1159

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic potential of thiazolidinediones as anticancer agents

By Panigrahy Dipak   Shen Lucy Q   Kieran Mark W   Kaipainen Arja  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 12, 2003-12 ,pp. : 1925-1937

Informa Healthcare

Access to resources Recommend Favorite

Microtubulin Binding Sites as Target for Developing Anticancer Agents

By  

Mini Reviews in Medicinal Chemistry, Vol. 4, Iss. 10, 2004-12 ,pp. : 1077-1104

Bentham Science Publishers

Access to resources Recommend Favorite

Protein tyrosine kinase inhibitors as anticancer agents

By Supuran Claudiu T   Scozzafava Andrea  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 1, 2004-01 ,pp. : 35-53

Informa Healthcare

Access to resources Recommend Favorite

Kinesin spindle protein Inhibitors as anticancer agents

By Jiang Cheng   You Qidong   Li Zhiyu   Guo Qinglong  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 11, 2006-11 ,pp. : 1517-1532

Informa Healthcare

Access to resources Recommend Favorite